Key facts
- This page summarizes Robert Thomas Dechant's Form 4 filing for IBEX Ltd (IBEX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Feb 2025, 16:57.
Robert Thomas Dechant - 10 Feb 2025 Form 4 Insider Report for IBEX Ltd (IBEX)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- IBEX
- Reported as of
- 10 Feb 2025
- Net transaction value
- -$59,482
- SEC form
- 4
- Accepted by SEC
- 12 Feb 2025, 16:57:00 UTC
- Prior SEC filing
- 07 Feb 2025
- Next SEC filing
- 14 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- Lisa Lenstrohm, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Thomas Dechant filed Form 4 for IBEX Ltd (IBEX) on 12 Feb 2025.
Change
- Previous filing in this sequence was filed on 07 Feb 2025.
- Current net transaction value: -$59,482.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IBEX
transaction
Common Shares
Sale
- Transaction value
- $1,525
- Shares
- -61
- Change %
- -0.03%
- Price
- $25.00
- Shares after
- 220,951
- Date
- 10 Feb 2025
- Ownership
- Direct
IBEX
transaction
Common Shares
Sale
- Transaction value
- $57,957
- Shares
- -2,318
- Change %
- -1%
- Price
- $25.00
- Shares after
- 218,633
- Date
- 11 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 1 footnote
Footnote F1
This transaction was executed in multiple trades at prices ranging from $25.00 to $25.015; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.